Malko, R.; Shannon, H.E.; Dobrota, E.A.; Kreklau, K.E.; Stevens, L.K.; Jackson, K.W.; Saadatzadeh, M.R.; Pandya, P.H.; Pollok, K.E.
Reframing RB Tumor Suppressor Dysfunction as a Therapeutic Vulnerability in Cancer. Cancers 2026, 18, 1175.
https://doi.org/10.3390/cancers18071175
AMA Style
Malko R, Shannon HE, Dobrota EA, Kreklau KE, Stevens LK, Jackson KW, Saadatzadeh MR, Pandya PH, Pollok KE.
Reframing RB Tumor Suppressor Dysfunction as a Therapeutic Vulnerability in Cancer. Cancers. 2026; 18(7):1175.
https://doi.org/10.3390/cancers18071175
Chicago/Turabian Style
Malko, Rada, Harlan E. Shannon, Erika A. Dobrota, Keiko E. Kreklau, Lauren K. Stevens, Kyle W. Jackson, M. Reza Saadatzadeh, Pankita H. Pandya, and Karen E. Pollok.
2026. "Reframing RB Tumor Suppressor Dysfunction as a Therapeutic Vulnerability in Cancer" Cancers 18, no. 7: 1175.
https://doi.org/10.3390/cancers18071175
APA Style
Malko, R., Shannon, H. E., Dobrota, E. A., Kreklau, K. E., Stevens, L. K., Jackson, K. W., Saadatzadeh, M. R., Pandya, P. H., & Pollok, K. E.
(2026). Reframing RB Tumor Suppressor Dysfunction as a Therapeutic Vulnerability in Cancer. Cancers, 18(7), 1175.
https://doi.org/10.3390/cancers18071175
